Pursuant to Listing Rule 17.1, Neurotech International Limited (ASX: NTI) (“the Company”) requests a trading halt for it’s securities for pre-open on Monday 25 September 2017. The trading halt is requested pending the announcement by the Company of a progress update on the independent US clinical trial of Mente Autism.
We are waiting on results
But hey Mente is a complete flop
Come in and register and waste more of your time
Or we HOPE significant outcomes from the trial.
NTI Price at posting:
16.5¢ Sentiment: Buy Disclosure: Held
